Amgen’s request to gain full approval of Lumakras in non-small cell lung cancer has been rejected by the FDA. The California pharma will now have to conduct an additional confirmatory trial to gain ...

I wish to draw the public’s attention to a matter of grave importance to me which I have pursued unsuccessfully for the past two decades. I am a former Overseer of the Ordinance NDC where I worked for ...